| | 143090-92-0 Basic information More.. |
| Product Name: | Anakinra | | Synonyms: | Anakinra;Kineret;Unii-9013duq28k;Interleukin1 receptor antagonist (huMan isoforM x reduced),N2-L-Methionyl- (9CI);Recombinant human interleukin-1 receptor antagonist,rhIL-1ra;Anakinra, Kineret, Recombinant Human Interleukin1 receptor antagonist, rhIL-1Ra;Anakinra, Interleukin1 receptor antagonist, IL-1ra, Kineret;Anakinra, Kineret, Recombinant Human Interleukin1 receptor antagonist | | CAS: | 143090-92-0 | | MF: | C20H23N5O7S2 | | MW: | 509.562 | | EINECS: | | | Mol File: | 143090-92-0.mol |  |
Use
Anakinra is the first IL-1Rα to be approved for use in adults with moderate to severe active rheumatoid arthritis who have not responded adequately to conventional DMARD therapy. It may be used either alone or in combination with methotrexate. Anakinra is supplied in single-use, prefilled, glass syringes as sterile, clear, preservative-free solution that is administered daily as a self-administered subcutaneous injection under the skin.
|
|
143090-92-0
Recommend Suppliers |
|